ORBIMED ADVISORS LLC Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$5.5B
Holdings
139
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (139 positions)
| Stock | Value |
|---|---|
SVASINOVAC BIOTECH LTD | $349.5M |
BMYBRISTOL-MYERS SQUIBB CO | $193.9M |
HUMHUMANA INC | $171.2M |
HZNPHORIZON THERAPEUTICS PUB L | $168.2M |
BSXBOSTON SCIENTIFIC CORP | $162.9M |
—TURNING POINT THERAPEUTICS I | $151.4M |
SWTXSPRINGWORKS THERAPEUTICS INC | $148.4M |
UNHUNITEDHEALTH GROUP INC | $144.4M |
PFEPFIZER INC | $143.9M |
BMRNBIOMARIN PHARMACEUTICAL INC | $140.9M |
SGENUSDSEAGEN INC | $130.5M |
ABBVABBVIE INC | $122.5M |
EWTXEDGEWISE THERAPEUTICS INC | $112.1M |
VRTXVERTEX PHARMACEUTICALS INC | $109.1M |
TORCEURADICET BIO INC | $108.7M |
—SIERRA ONCOLOGY INC | $108.0M |
—BIOHAVEN PHARMACTL HLDG CO L | $104.8M |
ISRGINTUITIVE SURGICAL INC | $103.8M |
ARQTARCUTIS BIOTHERAPEUTICS INC | $101.9M |
1T7TRICIDA INC | $99.5M |
EWEDWARDS LIFESCIENCES CORP | $96.2M |
—THESEUS PHARMACEUTICALS INC | $94.2M |
PMVPPMV PHARMACEUTICALS INC | $93.5M |
SYKSTRYKER CORPORATION | $87.7M |
NBIXNEUROCRINE BIOSCIENCES INC | $82.8M |
ARGXARGENX SE | $73.5M |
MRTXEURMIRATI THERAPEUTICS INC | $73.2M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $65.3M |
NTRANATERA INC | $64.2M |
TMOTHERMO FISHER SCIENTIFIC INC | $61.6M |
CRNXCRINETICS PHARMACEUTICALS IN | $59.6M |
CMPXCOMPASS THERAPEUTICS INC | $58.2M |
EVHEVOLENT HEALTH INC | $54.6M |
PRLDPRELUDE THERAPEUTICS INC | $52.4M |
—KINNATE BIOPHARMA INC | $51.0M |
ABCLABCELLERA BIOLOGICS INC | $47.2M |
RPTXREPARE THERAPEUTICS INC | $46.5M |
KROSKEROS THERAPEUTICS INC | $46.4M |
SNDXSYNDAX PHARMACEUTICALS INC | $44.7M |
SIBNSI-BONE INC | $44.5M |
GHGUARDANT HEALTH INC | $43.7M |
GRCLGRACELL BIOTECHNOLOGIES INC | $43.4M |
—MERSANA THERAPEUTICS INC | $41.6M |
XENEXENON PHARMACEUTICALS INC | $40.4M |
XTNTXTANT MED HLDGS INC | $37.9M |
SPRYSILVERBACK THERAPEUTICS INC | $37.1M |
—VECTIVBIO HLDG AG | $35.0M |
NVLSEURALPINE IMMUNE SCIENCES INC | $34.7M |
JANXJANUX THERAPEUTICS INC | $34.6M |
THCTENET HEALTHCARE CORP | $34.5M |
290ACHINOOK THERAPEUTICS INC | $33.2M |
PCVXVAXCYTE INC | $32.9M |
ACRSACLARIS THERAPEUTICS INC | $32.5M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $30.9M |
IMAPRELUDE THERAPEUTICS INC | $29.7M |
IMAIKENA ONCOLOGY INC | $28.7M |
VRNAVERONA PHARMA PLC | $23.9M |
SCPHSCPHARMACEUTICALS INC | $23.1M |
BIIBBIOGEN INC | $22.8M |
TELATELA BIO INC | $21.2M |
PASGPASSAGE BIO INC | $21.1M |
—DECIBEL THERAPEUTICS INC | $20.8M |
NPCENEUROPACE INC | $19.9M |
RXSTRXSIGHT INC | $19.5M |
MGTXMEIRAGTX HLDGS PLC | $18.9M |
TVTXTRAVERE THERAPEUTICS INC | $18.7M |
PGNYPROGYNY INC | $18.2M |
GILDGILEAD SCIENCES INC | $17.8M |
ALXOALX ONCOLOGY HLDGS INC | $17.7M |
ISIIONIS PHARMACEUTICALS INC | $16.8M |
IVVDADAGIO THERAPEUTICS INC | $16.6M |
QUREUNIQURE NV | $16.3M |
GHRSGH RESEARCH PLC | $16.2M |
RAPTEURRAPT THERAPEUTICS INC | $15.8M |
VTYXVENTYX BIOSCIENCES INC | $15.8M |
AMGNAMGEN INC | $13.9M |
BLUBELLUS HEALTH INC NEW | $13.4M |
REGNREGENERON PHARMACEUTICALS | $13.1M |
OPHTEURIVERIC BIO INC | $13.1M |
—IKENA ONCOLOGY INC | $13.0M |
NXTCNEXTCURE INC | $12.7M |
SGFYGBPSIGNIFY HEALTH INC | $12.4M |
TBPHTHERAVANCE BIOPHARMA INC | $12.4M |
BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | $12.2M |
VTGNUSDVISTAGEN THERAPEUTICS INC | $11.8M |
ETNBGBP89BIO INC | $11.8M |
KZRKEZAR LIFE SCIENCES INC | $11.7M |
MISTMILESTONE PHARMACEUTICALS IN | $11.2M |
MREOMEREO BIOPHARMA GROUP PLC | $10.9M |
DHR 5 04/15/23 BDANAHER CORPORATION | $10.6M |
—GEMINI THERAPEUTICS INC | $9.8M |
CMMBCHEMOMAB THERAPEUTICS LTD | $9.5M |
TERNTERNS PHARMACEUTICALS INC | $9.4M |
ORICORIC PHARMACEUTICALS INC | $9.4M |
ERASERASCA INC | $9.3M |
BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | $9.0M |
JNCEEURJOUNCE THERAPEUTICS INC | $8.9M |
CGEMCULLINAN ONCOLOGY INC | $8.6M |
XBISPDR SER TR | $8.3M |
—FUSION PHARMACEUTICALS INC | $8.0M |
Page 1 of 2Next